Case File
efta-efta00707847DOJ Data Set 9OtherFrom: "James Henderson" <1
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00707847
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "James Henderson" <1
To: "Jeffrey Epstein" <[email protected]>, "ferg"
Subject: RE:
Date: Tue, 24 May 2011 09:57:06 +0000
Inline-Images: image001.gif; image002.gif
I am confused
Your lawyer contacted us with a proposed letter to be sent out but never came back to the questions we put to him
regarding proposed distribution and usage so we have been unable to take this further.
In the meantime the Duchess has followed your guidance in interviews with reference to questions about you.
James Henderson
Managing Director
Pelham Bell Pottinger
Pelham Bell Pottinger
6th Floor. Holborn Gate. 330 High Holborn London. WC1V 7QD
The award winning Bell Pottinger Group is part of Chime Communications plc
AWARDS
prca%
•
IIITheHolmesReport
2011 DMA Orpa. Ceowaseco M Ur Ye
Bell Pottinger Group
We are committed to protecting the environment so please do not print this email unless you really need to.
A CarbonNeutral® company
From: Jeffrey Epstein [[email protected]]
Sent: 24 May 2011 10:54
To: ferg
Cc: James Henderson
Subject:
I have not received your letter , setting the record straight .. Henderson told me I would have it three weeks ago.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
EFTA00707847
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
CONFIDENTIALITY NOTICE AND LEGAL LIABILITY WAIVER: The content of this email and any attachments are CONFIDENTIAL and may contain privileged
information. II you are not the addressee it may be UNLAWFUL for you to read. copy. distribute. disclose or otherwise use the information contained herein. The
content of the message and or attachments may not reflect the view and opinions of the originating company or any party it is representing.
II you are NOT the intended recipient then please email back to itsupportgtchime.plc.uk
EFTA00707848
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
OtherUnknown
FEDWIRE PAYMENT DEBIT ADVICE
DOJ EFTA Data Set 10 document EFTA01273102
16p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.